Log in

The Cooper Companies Stock Forecast, Price & News

+7.73 (+2.29 %)
(As of 12/4/2020 12:00 AM ET)
Today's Range
Now: $345.71
50-Day Range
MA: $338.19
52-Week Range
Now: $345.71
Volume454,657 shs
Average Volume322,652 shs
Market Capitalization$18.44 billion
P/E Ratio61.84
Dividend Yield0.02%
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.
The Cooper Companies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.05 out of 5 stars

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies



Sales & Book Value

Annual Sales$2.65 billion
Cash Flow$18.69 per share
Book Value$73.20 per share


Net Income$466.70 million


Market Cap$18.44 billion
Next Earnings Date3/4/2021 (Estimated)
+7.73 (+2.29 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

The Cooper Companies (NYSE:COO) Frequently Asked Questions

How has The Cooper Companies' stock price been impacted by COVID-19 (Coronavirus)?

The Cooper Companies' stock was trading at $323.89 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, COO stock has increased by 6.7% and is now trading at $345.71.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of The Cooper Companies?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Cooper Companies in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for The Cooper Companies
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than The Cooper Companies?

Wall Street analysts have given The Cooper Companies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The Cooper Companies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is The Cooper Companies' next earnings date?

The Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for The Cooper Companies

How were The Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NYSE:COO) announced its quarterly earnings results on Wednesday, December, 2nd. The medical device company reported $3.16 EPS for the quarter, topping the Zacks' consensus estimate of $3.09 by $0.07. The medical device company had revenue of $681.60 million for the quarter, compared to analyst estimates of $678.32 million. The Cooper Companies had a return on equity of 13.19% and a net margin of 11.40%. The Cooper Companies's quarterly revenue was down 1.5% compared to the same quarter last year. During the same quarter last year, the company posted $3.30 EPS.
View The Cooper Companies' earnings history

How often does The Cooper Companies pay dividends? What is the dividend yield for The Cooper Companies?

The Cooper Companies announced a Semi-Annual dividend on Thursday, July 9th. Shareholders of record on Thursday, July 23rd will be given a dividend of $0.03 per share on Friday, August 7th. The ex-dividend date is Wednesday, July 22nd.
View The Cooper Companies' dividend history

What guidance has The Cooper Companies issued on next quarter's earnings?

The Cooper Companies updated its first quarter earnings guidance on Thursday, December, 3rd. The company provided earnings per share guidance of $2.66-$2.86 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.95. The company issued revenue guidance of $642-$670 million, compared to the consensus revenue estimate of $670.06 million.

What price target have analysts set for COO?

12 Wall Street analysts have issued 12 month target prices for The Cooper Companies' stock. Their forecasts range from $291.00 to $380.00. On average, they anticipate The Cooper Companies' share price to reach $345.50 in the next twelve months. This suggests that the stock has a possible downside of 0.1%.
View analysts' price targets for The Cooper Companies

Who are some of The Cooper Companies' key competitors?

What other stocks do shareholders of The Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Cooper Companies investors own include The Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

Who are The Cooper Companies' key executives?

The Cooper Companies' management team includes the following people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 50, Pay $2.1M)
  • Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 41, Pay $789.08k)
  • Mr. Daniel G. McBride, Exec. VP & COO (Age 56, Pay $1.44M)
  • Dr. Robert D. Auerbach, Special Advisor to the CEO (Age 59, Pay $724.2k)
  • Ms. Holly R. Sheffield, Pres of CooperSurgical Inc (Age 49, Pay $995.03k)
  • Mr. Agostino Ricupati, Sr. VP of Fin. & Tax and Chief Accounting Officer (Age 53)
  • Mr. Kim Duncan, VP of Investor Relations & Risk Management
  • Mr. Mark J. Drury, VP, Gen. Counsel & Corp. Sec.
  • Mr. Randal L. Golden, Legal Advisor (Age 58)
  • Mr. Juan Carlos Aragón, Pres of CooperVision Specialty EyeCare Division

What is The Cooper Companies' stock symbol?

The Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Who are The Cooper Companies' major shareholders?

The Cooper Companies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.66%), Veritas Asset Management LLP (4.37%), State Street Corp (4.07%), Massachusetts Financial Services Co. MA (2.92%), Allianz Asset Management GmbH (1.48%) and Victory Capital Management Inc. (1.14%). Company insiders that own The Cooper Companies stock include Agostino Ricupati, Albert G White III, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg.
View institutional ownership trends for The Cooper Companies

Which institutional investors are selling The Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Massachusetts Financial Services Co. MA, AQR Capital Management LLC, PGGM Investments, BlackRock Inc., Handelsbanken Fonder AB, Cubist Systematic Strategies LLC, and Allianz Asset Management GmbH. Company insiders that have sold The Cooper Companies company stock in the last year include Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, and Robert D Auerbach.
View insider buying and selling activity for The Cooper Companies

Which institutional investors are buying The Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Neuberger Berman Group LLC, Victory Capital Management Inc., Wells Fargo & Company MN, State of Tennessee Treasury Department, Ceredex Value Advisors LLC, WCM Investment Management LLC, and Assenagon Asset Management S.A.. Company insiders that have bought The Cooper Companies stock in the last two years include Agostino Ricupati, Albert G White III, Allan E Rubenstein, and Holly R Sheffield.
View insider buying and selling activity for The Cooper Companies

How do I buy shares of The Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is The Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $345.71.

How big of a company is The Cooper Companies?

The Cooper Companies has a market capitalization of $18.44 billion and generates $2.65 billion in revenue each year. The medical device company earns $466.70 million in net income (profit) each year or $12.35 on an earnings per share basis. The Cooper Companies employs 12,000 workers across the globe.

What is The Cooper Companies' official website?

The official website for The Cooper Companies is www.coopercos.com.

How can I contact The Cooper Companies?

The Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.